Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,080	586.99	1,862	470.49	615.36	365.84
Short-Term Investments	-	280	230	-	20	-
Trading Asset Securities	2,199	2,759	419.6	1,567	1,625	2,225
Cash & Short-Term Investments	3,279	3,626	2,512	2,037	2,260	2,591
Cash Growth	8.22%	44.37%	23.29%	-9.86%	-12.78%	173.64%
Accounts Receivable	333.69	389	260.17	150.85	14.83	0.29
Other Receivables	8.77	29.26	29.07	6.82	3.58	2.28
Receivables	342.46	418.26	289.24	157.68	18.42	2.57
Inventory	37.9	30.56	62.95	32.07	20.8	10.78
Prepaid Expenses	-	2.15	3.18	2.5	-	-
Other Current Assets	335.33	103.21	40.79	56.69	75.42	74.69
Total Current Assets	3,994	4,180	2,908	2,286	2,375	2,679
Property, Plant & Equipment	521.29	516.37	526.64	539.94	404.03	206.88
Long-Term Investments	167.31	244.4	145.26	52.73	38.37	20
Other Intangible Assets	178.17	65.38	66.49	68.45	67.29	69.18
Long-Term Deferred Tax Assets	-	0	-	11.5	-	-
Long-Term Deferred Charges	158.33	168.12	0.71	0.57	2.11	2.71
Other Long-Term Assets	2,240	741.45	729.5	482.76	243.79	8.93
Total Assets	7,259	5,916	4,376	3,442	3,130	2,987
Accounts Payable	84.42	27.39	13.25	5.15	1.75	3.44
Accrued Expenses	247.39	482.4	314.33	152.68	96.96	93.58
Current Portion of Leases	1.72	0.99	1.43	1.66	4.72	-
Current Income Taxes Payable	161.42	67.45	5.4	6.98	-	0.36
Current Unearned Revenue	2.09	-	-	0.1	0.18	-
Other Current Liabilities	244.55	22.37	55.62	88.04	52.51	11.63
Total Current Liabilities	741.58	600.6	390.03	254.62	156.12	109.01
Long-Term Leases	2.03	0.3	0.39	0.3	0.68	-
Long-Term Deferred Tax Liabilities	13.66	28.77	0.14	-	-	-
Other Long-Term Liabilities	3.27	3.65	3.65	0.2	0.2	-
Total Liabilities	760.53	633.32	394.22	255.12	156.99	109.01
Common Stock	450	450	450	450	450	450
Additional Paid-In Capital	3,279	3,254	3,175	3,100	3,031	2,957
Retained Earnings	2,657	1,401	264.02	-380.16	-510.68	-528.95
Comprehensive Income & Other	112.37	177.89	93.63	17.61	3.25	-
Shareholders' Equity	6,499	5,283	3,982	3,187	2,973	2,878
Total Liabilities & Equity	7,259	5,916	4,376	3,442	3,130	2,987
Total Debt	3.75	1.3	1.82	1.96	5.39	-
Net Cash (Debt)	3,275	3,625	2,510	2,035	2,255	2,591
Net Cash Growth	8.15%	44.42%	23.32%	-9.73%	-12.99%	209.60%
Net Cash Per Share	7.29	8.06	5.57	4.52	4.94	7.01
Filing Date Shares Outstanding	450	450	450	450	450	450
Total Common Shares Outstanding	450	450	450	450	450	450
Working Capital	3,253	3,580	2,518	2,032	2,219	2,570
Book Value Per Share	14.44	11.74	8.85	7.08	6.61	6.40
Tangible Book Value	6,321	5,217	3,916	3,119	2,906	2,809
Tangible Book Value Per Share	14.05	11.59	8.70	6.93	6.46	6.24
Buildings	-	508.81	494.91	470.35	116.73	116.73
Machinery	-	156.45	132.04	140.27	88.34	75.36
Construction In Progress	-	5.19	18.58	13.8	266.57	78.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.